![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » BARRIER THERAPEUTICS LAUNCHES DENAVIR IN CANADA
BARRIER THERAPEUTICS LAUNCHES DENAVIR IN CANADA
Barrier Therapeutics, Inc., a pharmaceutical company developing and commercializing products in the field of dermatology, today announced the commercial launch of Denavir (penciclovir cream) 1% in Canada. Denavir is a topical antiviral prescription medication indicated for the treatment of herpes labialis, also known as cold sores, in adults. This is the only topical antiviral product available by prescription for treating this condition.
Market
Wire
KEYWORDS FDAnews Drug Daily Bulletin
Upcoming Events
-
11Jul
-
18Jul
-
21Oct